{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:14:26Z","timestamp":1792034066271,"version":"4.4.0"},"reference-count":135,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum toxin type A (BTXA) has been used for over 25 years in the management of pediatric lower and upper limb hypertonia, with the first reports in 1993. The most common indication is the injection of the triceps surae muscle for the correction of spastic equinus gait in children with cerebral palsy. The upper limb injection goals include improvements in function, better positioning of the arm, and facilitating the ease of care. Neurotoxin type A is the most widely used serotype in the pediatric population. After being injected into muscle, the release of acetylcholine at cholinergic nerve endings is blocked, and a temporary denervation and atrophy ensues. Targeting the correct muscle close to the neuromuscular junctions is considered essential and localization techniques have developed over time. However, each technique has its own limitations. The role of BTXA is flexible, but limited by the temporary mode of action as a focal spasticity treatment and the restrictions on the total dose deliverable per visit. As a mode of treatment, repeated BTXA injections are needed. This literature reviewed BTXA injection techniques, doses and dilutions, the recovery of muscles and the impact of repeated injections, with a focus on the pediatric population. Suggestions for future studies are also discussed.<\/jats:p>","DOI":"10.3390\/toxins12070440","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:07:42Z","timestamp":1594033662000},"page":"440","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?"],"prefix":"10.3390","volume":"12","author":[{"given":"Heli","family":"S\u00e4til\u00e4","sequence":"first","affiliation":[{"name":"Department of Neuropediatrics, P\u00e4ij\u00e4t-H\u00e4me Central Hospital, Keskussairaalankatu 7, 15850 Lahti, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40272-019-00344-8","article-title":"Botulinum toxin in the management of children with cerebral palsy","volume":"21","author":"Multani","year":"2019","journal-title":"Pediatr. Drugs"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0966-6362(99)00054-5","article-title":"Recommendations for the use of botulinum toxin type A in the management of cerebral palsy","volume":"11","author":"Graham","year":"2000","journal-title":"Gait Posture"},{"key":"ref_4","unstructured":"Gage, J.R. (2004). Pathological gait and lever-arm dysfunction. The Treatment of Gait Problems in Cerebral Palsy, MacKeith Press. [1st ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1468-1331.2001.00046.x","article-title":"Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: Clinical implications","volume":"8","author":"Larsen","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0749-0712(03)00060-X","article-title":"Botulinum toxin A in the management of upper limb spasticity in cerebral palsy","volume":"19","author":"Chin","year":"2003","journal-title":"Hand Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1468-1331.2001.00047.x","article-title":"Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: Child characteristics that predict a positive outcome","volume":"8","author":"Fehlings","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00128072-200305010-00002","article-title":"Spasticity associated with cerebral palsy in children. Guidelines for the use of botulinum A toxin","volume":"5","author":"Koman","year":"2003","journal-title":"Pediatr. Drugs"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1017\/S001216220700014X.x","article-title":"Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy","volume":"49","author":"Desloovere","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-2000-15289","article-title":"Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia","volume":"31","author":"Larsen","year":"2000","journal-title":"Neuropediatrics"},{"key":"ref_11","unstructured":"Mayer, N.H., and Simpson, D.M. (2002). Cerebral palsy: A rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Spasticity: Etiology, Evaluation, Management and the Role of Botulinum Toxin, Wiley."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2009.09.005","article-title":"The updated European Consensus 2009 on the use of botulinum toxin for children with cerebral palsy","volume":"14","author":"Heinen","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03126.x","article-title":"Botulinum toxin assessment, intervention and aftercare for lower limb spasticity in children with cerebral palsy: International consensus statement","volume":"17","author":"Love","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2010.03127.x","article-title":"Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: International consensus statement","volume":"17","author":"Fehlings","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03033938","article-title":"Botulinum toxin treatment of children with cerebral palsy\u2014A short review of different injection techniques","volume":"9","author":"Schroeder","year":"2006","journal-title":"Neurotox. Res."},{"key":"ref_16","unstructured":"S\u00e4til\u00e4, H. (2007). Botulinum Toxin A Treatment in Children with Spastic Cerebral Palsy: Studies on Injection Techniques and Doses. [Ph.D. Thesis, Tampere University]. Available online: http:\/\/urn.fi\/urn:isbn:978-951-44-7078-3."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1469-8749.2010.03816.x","article-title":"Localization of the motor endplate zone in human skeletal muscles of the lower limb: Anatomical guidelines for injection with botulinum toxin","volume":"53","author":"Molenaers","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: Biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharm. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/mus.880171207","article-title":"Serial neurophysiological studies of intramuscular botulinum-A toxin in humans","volume":"17","author":"Hamjian","year":"1994","journal-title":"Muscle Nerve"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1212\/WNL.46.5.1382","article-title":"Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A","volume":"46","author":"Sloop","year":"1996","journal-title":"Neurology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archneur.56.8.914","article-title":"Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system","volume":"56","author":"Naumann","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002060-195904000-00005","article-title":"Topography of terminal motor innervation in striated muscles from stillborn infants","volume":"38","author":"Christensen","year":"1959","journal-title":"Am. J. Phys. Med."},{"key":"ref_23","unstructured":"Coers, C., and Woolf, A.L. (1959). The Innervation of Muscle: A Biopsy Study, Charles C Thomas."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03033928","article-title":"Muscle fiber orientation in muscles commonly injected with botulinum toxin: An anatomical pilot study","volume":"9","author":"Deshpande","year":"2006","journal-title":"Neurotox. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/(SICI)1097-4598(199708)20:8<1041::AID-MUS18>3.0.CO;2-Y","article-title":"Flexor digitorum superficialis: Locations of individual muscle bellies for botulinum toxin injections","volume":"20","author":"Bickerton","year":"1997","journal-title":"Muscle Nerve"},{"key":"ref_26","first-page":"35","article-title":"Innervation zones of the upper and lower limb muscles estimated by using multichannel surface EMG","volume":"29","author":"Saitou","year":"2000","journal-title":"J. Hum. Ergol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PHM.0b013e3181d8a116","article-title":"Extra- and intramuscular nerve distribution patterns of the muscles of the ventral compartment of the forearm","volume":"89","author":"Won","year":"2010","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_28","first-page":"5485","article-title":"Intramuscular nerve distribution patterns of anterior forearm muscles in children: A guide for botulinum toxin injection","volume":"8","author":"Yang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00276-002-0022-9","article-title":"Intramuscular distribution of nerves in the human triceps surae muscle: Anatomical bases for treatment of spastic drop foot with botulinum toxin","volume":"24","author":"Parratte","year":"2002","journal-title":"Surg. Radiol. Anat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.blo.0000165856.38166.9a","article-title":"Motor points for neuromuscular blockade of the adductor muscle group","volume":"437","author":"Crystal","year":"2005","journal-title":"Clin. Orthopaed. Rel. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.phm.0000176341.85398.a9","article-title":"Anatomic localization of motor points in gastrocnemius and soleus muscles","volume":"84","author":"Kim","year":"2005","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/01.bpb.0000228387.94065.ff","article-title":"Botulinum toxin injection site localization for the tibialis posterior muscle","volume":"15","author":"Oddy","year":"2006","journal-title":"J. Pediatr. Orthop. B"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00276-009-0490-2","article-title":"Extra- and intramuscular nerves distributions of the triceps surae muscle as a basis for muscle resection and botulinum toxin injections","volume":"31","author":"Sheverdin","year":"2009","journal-title":"Surg. Radiol. Anat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.21660","article-title":"Localization of motor nerve branches of the human psoas muscle","volume":"42","author":"Hubens","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis","volume":"16","author":"Shaari","year":"1993","journal-title":"Muscle Nerve"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W","article-title":"Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model","volume":"21","author":"Childers","year":"1998","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.PHM.0000160006.51859.AE","article-title":"Botulinum toxin treatment of spastic equinus in cerebral palsy: A randomized trial comparing two injection sites","volume":"84","author":"Iisalo","year":"2005","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ridd.2012.11.016","article-title":"Botulinum toxin type A injections in the psoas muscle of children with cerebral palsy: Muscle atrophy after motor end plate-targeted injections","volume":"34","author":"Verhaegen","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/dmcn.12667","article-title":"Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy","volume":"57","author":"Desloovere","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00002060-199611000-00013","article-title":"Comparison of two injection techniques using botulinum toxin in spastic hemiplegia","volume":"75","author":"Childers","year":"1996","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0269215513514983","article-title":"Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: A randomized double-blind controlled trial","volume":"28","author":"Im","year":"2014","journal-title":"Clin. Rehabil."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: A double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.clinph.2010.11.018","article-title":"Botulinum toxin has an increased effect when targeted toward the muscle\u2019s endplate zone: A high-density surface EMG guided study","volume":"122","author":"Lapatki","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002341-199103000-00007","article-title":"Innervation zone of orbicularis oculi muscle and implications for botulinum toxin therapy","volume":"7","author":"Borodic","year":"1991","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hed.2880140108","article-title":"Botulinum A toxin for spasmodic torticollis: Multiple vs. single injection points per muscle","volume":"14","author":"Borodic","year":"1992","journal-title":"Head Neck"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.apmr.2007.10.022","article-title":"Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia","volume":"89","author":"Mayer","year":"2008","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/PHM.0b013e31816ddaa9","article-title":"Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: A randomized trial comparing single and multiple injection sites","volume":"87","author":"Iisalo","year":"2008","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01241398-199307000-00013","article-title":"Management of cerebral palsy with botulinum-A toxin: Preliminary investigation","volume":"13","author":"Koman","year":"1993","journal-title":"J. Pediatr. Orthop."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-8749.1994.tb11864.x","article-title":"Botulinum toxin in the management of the lower limb in cerebral palsy","volume":"36","author":"Cosgrove","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mpd.2000.108393","article-title":"An evaluation of botulinum-A toxin injections to improve upper extremity function in children with cerebral palsy","volume":"137","author":"Fehlings","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.bpo.0000150819.72608.86","article-title":"Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy. A comparison between manual needle placement and placement guided by electrical stimulation","volume":"25","author":"Chin","year":"2005","journal-title":"J. Pediatr. Orthop."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2002-34500","article-title":"Sonography-guided injection of botulinum toxin A in children with cerebral palsy","volume":"33","author":"Berweck","year":"2002","journal-title":"Neuropediatrics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.rehab.2014.09.010","article-title":"Pain during injections of botulinum toxin in children: Influence of the localization technique","volume":"57","author":"Gambart","year":"2014","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.apmr.2008.10.025","article-title":"Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography","volume":"90","author":"Yang","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0269215509335295","article-title":"A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy","volume":"23","author":"Xu","year":"2009","journal-title":"Clin. Rehabil."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PHM.0b013e3181ca24ac","article-title":"Botulinum toxin A injection into calf muscles for treatment of spastic equinus in cerebral palsy: A controlled trial comparing sonography and electric stimulation-guided injection technique: A preliminary report","volume":"89","author":"Kwon","year":"2010","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_57","first-page":"1","article-title":"The role of electromyography in guiding botulinum toxin injections for focal dystonia and spasticity","volume":"12","author":"Ajax","year":"1998","journal-title":"J. Neuro. Rehabil."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.58.5.805","article-title":"Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia","volume":"58","author":"Molloy","year":"2002","journal-title":"Neurology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2340\/16501977-0970","article-title":"Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: Manual needle placement and electrical stimulation guidance compared using ultrasonography","volume":"44","author":"Picelli","year":"2012","journal-title":"J. Rehabil. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2340\/16501977-1871","article-title":"Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: Manual needle placement evaluated using ultrasonography","volume":"46","author":"Picelli","year":"2014","journal-title":"J. Rehabil. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/mus.23410","article-title":"Manual needle placement: Accuracy of botulinum toxin A injections","volume":"46","author":"Schnitzler","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Scaglione, F. (2016). Conversion ratio between Botox, Dysport, and Xeomin in clinical practice. Toxins, 8.","DOI":"10.3390\/toxins8030065"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mus.23983","article-title":"Systematic test of neurotoxin dose and volume on muscle function in a rat model","volume":"49","author":"Hulst","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hed.2880120504","article-title":"Botulinum A toxin for the treatment of spasmodic torticollis: Dysphagia and regional toxin spread","volume":"12","author":"Borodic","year":"1990","journal-title":"Head Neck"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/0883073811420874","article-title":"Spread of botulinum neurotoxin type A at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: Short-term neurophysiological and clinical study","volume":"27","author":"Frasson","year":"2012","journal-title":"J. Child Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000008122","article-title":"Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle","volume":"43","author":"Dressler","year":"2000","journal-title":"Eur. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0269215510367557","article-title":"Effects of botulinum toxin A on calf muscles in children with cerebral palsy: A systematic review","volume":"24","author":"Koog","year":"2010","journal-title":"Clin. Rehabil."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-2007-973475","article-title":"Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized, double-blind study of \u201chigh-dose\u201d versus \u201clow-dose\u201d treatment","volume":"30","author":"Wissel","year":"1998","journal-title":"Neuropediatrics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-8749.2002.tb00328.x","article-title":"Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy","volume":"44","author":"Polak","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1469-8749.2002.tb00268.x","article-title":"Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, dose-ranging study","volume":"44","author":"Baker","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e20152830","DOI":"10.1542\/peds.2015-2830","article-title":"AbobotulinumtoxinA for equinus foot deformity in cerebral palsy: A randomized controlled trial","volume":"137","author":"Delgado","year":"2016","journal-title":"Pediatrics"},{"key":"ref_74","first-page":"234","article-title":"Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity","volume":"43","author":"Bakheit","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-2007-964998","article-title":"Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort","volume":"37","author":"Koivikko","year":"2006","journal-title":"Neuropediatrics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/PHM.0b013e31821f6c40","article-title":"Treating spastic equinus foot from cerebral palsy with botulinum toxin type-A: What factors influence the results? An analysis of 189 consecutive cases","volume":"90","year":"2011","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3349\/ymj.2006.47.5.589","article-title":"Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: A literature review","volume":"47","author":"Park","year":"2006","journal-title":"Yonsei Med. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1469-8749.2007.00331.x","article-title":"A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity","volume":"49","author":"Kawamura","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0012162203000380","article-title":"Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis","volume":"45","author":"Kim","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002060-200205000-00007","article-title":"Botulinum toxin in upper limb spasticity after acquired brain injury","volume":"81","author":"Francisco","year":"2002","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.PHM.0000137314.38806.95","article-title":"Botulinum toxin for lower limb spasticity in children with cerebral palsy: A single-blinded trial comparing dilution techniques","volume":"83","author":"Lee","year":"2004","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2340\/16501977-0418","article-title":"Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: A randomized controlled trial","volume":"41","author":"Lee","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/0269215508097861","article-title":"Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: A randomized trial comparing two injection volumes","volume":"23","author":"Hu","year":"2009","journal-title":"Clin. Rehabil."},{"key":"ref_84","first-page":"964","article-title":"Motor nerve sprouting in human orbicularis muscle after botulinum A injection","volume":"31","author":"Holds","year":"1990","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"Meunier","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxicon.2005.03.022","article-title":"Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle","volume":"46","author":"Dodd","year":"2005","journal-title":"Toxicon"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jor.20131","article-title":"How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats","volume":"24","author":"Shen","year":"2006","journal-title":"J. Orthop. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/mus.24576","article-title":"Dramatic changes in muscle contractile and structural properties after two botulinum toxin injections","volume":"52","author":"Minamoto","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.25707","article-title":"Recovery of rat muscle size but not function more than one-year after a single botulinum toxin injection","volume":"57","author":"Ward","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jor.21533","article-title":"Passive mechanical properties and related proteins change with botulinum neurotoxin A injection of normal skeletal muscle","volume":"30","author":"Thacker","year":"2012","journal-title":"J. Orthop. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/mus.24211","article-title":"Systems analysis of transcriptional data provides insights into muscle\u2019s biological response to botulinum toxin","volume":"50","author":"Mukund","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbiomech.2010.08.020","article-title":"Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox)","volume":"44","author":"Fortuna","year":"2011","journal-title":"J. Biomech."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jbiomech.2013.07.028","article-title":"Do skeletal muscle properties recover following repeat onabotulinum toxin A injections?","volume":"46","author":"Fortuna","year":"2013","journal-title":"J. Biomech."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbiomech.2012.09.025","article-title":"The effects of electrical stimulation exercise on muscles injected with botulinum toxin type-A (Botox)","volume":"46","author":"Fortuna","year":"2013","journal-title":"J. Biomech."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archopht.1991.01080030095046","article-title":"Histologic features of human orbicularis oculi treated with botulinum A toxin","volume":"109","author":"Harris","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"ref_96","first-page":"121","article-title":"Effects of repeated botulinum toxin injections on orbicularis oculi muscle","volume":"12","author":"Borodic","year":"1992","journal-title":"J. Clin. Neuro-Ophthalmol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/mds.22661","article-title":"Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers","volume":"24","author":"Schroeder","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"H\u00e4gglund, G., and Wagner, P. (2008). Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet. Disord., 9.","DOI":"10.1186\/1471-2474-9-150"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/dmcn.12124","article-title":"Passive muscle properties are altered in children with cerebral palsy before the age of 3 years and are difficult to distinguish clinically from spasticity","volume":"55","author":"Lorentzen","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/dmcn.13729","article-title":"Impaired muscle growth precedes development of increased stiffness of the triceps surae musculo-tendinous unit in children with cerebral palsy","volume":"60","author":"Lorentzen","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1469-8749.2010.03686.x","article-title":"Gross muscle morphology and structure in spastic cerebral palsy: A systematic review","volume":"52","author":"Barret","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_102","first-page":"CD003469","article-title":"Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)","volume":"1","author":"Hoare","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_103","first-page":"CD001408","article-title":"Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy","volume":"10","author":"Blumetti","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1469-8749.2011.03930.x","article-title":"No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy","volume":"53","author":"Alhusaini","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1469-8749.1999.tb00589.x","article-title":"The effect of botulinum toxin A on gastrocnemius length: Magnitude and duration of response","volume":"41","author":"Eames","year":"1999","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3349\/ymj.2014.55.5.1406","article-title":"Architectural changes of the gastrocnemius muscle after botulinum toxin type A injection in children with cerebral palsy","volume":"55","author":"Park","year":"2014","journal-title":"Yonsei Med. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jos.2017.10.012","article-title":"Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy","volume":"23","author":"Kawano","year":"2018","journal-title":"J. Orthop. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.24763","article-title":"Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A","volume":"53","author":"Valentine","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Smith, L.R., Ponten, E., Hedstr\u00f6m, Y., Ward, S.R., Chambers, H.G., Subramaniam, S., and Lieber, R.L. (2009). Novel transcriptional profile in wrist muscles from cerebral palsy patients. BMC Med. Genom., 2.","DOI":"10.1186\/1755-8794-2-44"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/BPO.0b013e3181558943","article-title":"Changes in the volume and length of the medial gastrocnemius after surgical recession in children with spastic diplegic cerebral palsy","volume":"27","author":"Fry","year":"2007","journal-title":"J. Pediatr. Orthop."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40279-019-01088-8","article-title":"Effect of immobilization on neuromuscular function in vivo in humans: A systematic review","volume":"49","author":"Campbell","year":"2019","journal-title":"Sports Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/dmcn.12200","article-title":"Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy","volume":"55","author":"Williams","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dmcn.13988","article-title":"Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: A 6-month prospective cohort study","volume":"60","author":"Alexander","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1469-8749.2010.03692.x","article-title":"How doctors think\u2014and treat with botulinum toxin","volume":"52","author":"Schroeder","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11832-013-0503-x","article-title":"The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: A 12-month prospective study","volume":"7","author":"Barber","year":"2013","journal-title":"J. Child Orthop."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/dmcn.14056","article-title":"Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy","volume":"61","author":"Schless","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1053\/apmr.2002.34286","article-title":"A systematic review of the effectiveness of strength-training programs for people with cerebral palsy","volume":"83","author":"Dodd","year":"2002","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2522\/ptj.20100356","article-title":"Muscle strengthening in children and adolescents with spastic cerebral palsy: Considerations for future resistance training protocols","volume":"81","author":"Verschuren","year":"2011","journal-title":"Phys. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ridd.2013.10.021","article-title":"Meta-analysis of the effect of strengthening interventions in individuals with cerebral palsy","volume":"35","author":"Park","year":"2014","journal-title":"Res. Dev. Disabil."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ridd.2016.06.003","article-title":"The impact of strength training on skeletal muscle morphology and architecture in children and adolescents with cerebral palsy: A systematic review","volume":"56","author":"Gillett","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Elvrum, A.-K.G., Braendvik, S.M., Saether, R., Lamvik, T., Vereijken, B., and Roeleveld, K. (2012). Effectiveness of resistance training in combination with botulinum toxin-A on hand and arm use in children with cerebral palsy: A pre-post intervention study. BMC Pediatr., 12.","DOI":"10.1186\/1471-2431-12-91"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/NRE-2012-0756","article-title":"Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: A randomized pilot study","volume":"30","author":"Bandholm","year":"2012","journal-title":"Neurorehabilitation"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3109\/09638288.2012.711898","article-title":"Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: The impact on muscle morphology and strength","volume":"35","author":"Williams","year":"2013","journal-title":"Disabil. Rehabil."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-8749.1994.tb11863.x","article-title":"Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse","volume":"36","author":"Cosgrove","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/dmcn.13135","article-title":"Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review","volume":"58","author":"Kahraman","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2008.03264.x","article-title":"Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy","volume":"51","author":"Kanovsky","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/dmcn.12962","article-title":"Injection frequency of botulinum toxin A for spastic equinus: A randomized clinical trial","volume":"58","author":"Blackburn","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1469-8749.2008.03189.x","article-title":"Long-term effects of botulinum toxin A in children with cerebral palsy","volume":"51","author":"Tedroff","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_129","first-page":"1","article-title":"Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: Who, when and why do we treat?","volume":"15","author":"Valentine","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Valentine, J., Davidson, S.A., Bear, N., Blair, E., Paterson, L., Ward, R., Forbes, D., and Elliot, C. (2020). A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term botulinum toxin type A use. BMC Pediatr., 20.","DOI":"10.1186\/s12887-019-1906-8"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01202412-200507000-00007","article-title":"Prevention of severe contractures might replace multilevel surgery in cerebral palsy: Results of a population-based health care programme and new techniques to reduce spasticity","volume":"14","author":"Andersson","year":"2005","journal-title":"J. Pediatr. Orthop. B"},{"key":"ref_132","first-page":"161","article-title":"The effects of quantitative gait assessment and botulinum toxin A on musculoskeletal surgery in children with cerebral palsy","volume":"88-A","author":"Molenaers","year":"2006","journal-title":"J. Bone Jt. Surg. (Am.)"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/dmcn.13480","article-title":"Prevention of hip displacement in children with cerebral palsy: A systematic review","volume":"59","author":"Miller","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.apmr.2015.05.002","article-title":"Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: A systematic review","volume":"96","author":"Grigoriu","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1469-8749.2009.03583.x","article-title":"Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy","volume":"52","author":"Naidu","year":"2010","journal-title":"Dev. Med. Child Neurol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/7\/440\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:04Z","timestamp":1760176084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/7\/440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":135,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["toxins12070440"],"URL":"https:\/\/doi.org\/10.3390\/toxins12070440","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]}}}